1
Diagnosis of Fatty Liver With Outpatient Ultrasound
Condition(s):Liver SteatosesLast Updated:December 3, 2019Recruiting
Fatty Liver: 1255 Clinical Trials, Page 1 of 13
Hide Studies Not Open or Pending
2
Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
Condition(s):Fatty LiverLast Updated:November 30, 2019Completed
3
Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway
Condition(s):Fatty LiverLast Updated:January 14, 2019Enrolling by invitation
4
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:September 25, 2019Recruiting
5
Metabolic Syndrome and Non-alcoholic Fatty Liver During Pregnancy
Condition(s):Fatty Liver; Gestational DiabetesLast Updated:April 7, 2019Recruiting
6
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
Condition(s):Hepatic Steatosis; MRI; Liver Biopsy; QuantificationLast Updated:May 4, 2017Unknown status
7
Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients
Condition(s):Nonalcoholic Fatty Liver Disease (NAFLD)Last Updated:August 15, 2019Enrolling by invitation
8
Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:June 25, 2014Completed
9
Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty Liver
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:October 30, 2016Unknown status
10
Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)
Condition(s):Fatty Liver DiseaseLast Updated:December 10, 2019Not yet recruiting
11
Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver Disease Without Non-Alcoholic Steatohepatitis (Disorder); Non-alcoholic SteatohepatitisLast Updated:October 24, 2019Recruiting
12
Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth
Condition(s):Hepatic Steatosis; Fatty LiverLast Updated:November 13, 2019Recruiting
13
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy
Condition(s):Fatty LiverLast Updated:December 23, 2010Completed
14
Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:November 22, 2019Recruiting
15
Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease
Condition(s):Fatty Liver; Non-alcoholic Fatty Liver DiseaseLast Updated:August 4, 2016Completed
16
Complex Imaging Assessment of Steatosis
Condition(s):Fatty LiverLast Updated:January 27, 2016Unknown status
17
Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:April 25, 2017Withdrawn
18
ASSOCIATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND DIABETES MELLITUS
Condition(s):Non-alcoholic Fatty Liver Disease (NAFLD)Last Updated:November 27, 2013Unknown status
19
Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI
Condition(s):Type 2 Diabetes; Non-alcoholic Fatty Liver DiseaseLast Updated:October 3, 2016Withdrawn
20
A Pilot Study to Explore the Role of Gut Flora in Fatty Liver
Condition(s):Fatty LiverLast Updated:November 8, 2019Not yet recruiting
21
Effectiveness and Adherence of Modified Alternate-day Calorie Restriction (MACR) in Non-Alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:December 29, 2018Completed
22
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD
Condition(s):Nonalcoholic Fatty Liver; Nonalcoholic SteatohepatitisLast Updated:October 29, 2018Recruiting
23
Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver Disease
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:August 22, 2018Recruiting
24
Genetics of Fatty Liver Disease in Children
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:December 6, 2017Completed
25
Association Between Non-alcoholic Fatty Liver Disease and Iron Status
Condition(s):NAFLD – Non Alcoholic Fatty Liver DiseaseLast Updated:September 19, 2012Unknown status
26
Early Detection of Advanced Fatty Liver Disease
Condition(s):Non-alcoholic Fatty Liver Disease; Liver FibrosisLast Updated:August 8, 2019Recruiting
27
Assessment of Renal Changes in Patients With Non Alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver Disease; Chronic Kidney DiseasesLast Updated:April 3, 2018Not yet recruiting
28
Chia Supplementation and Non Alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver Disease; Dietary ModificationLast Updated:May 7, 2019Completed
29
Fatty Liver in Inflammatory Bowel Disease (IBD) Patients
Condition(s):Inflammatory Bowel Disease; Fatty LiverLast Updated:March 4, 2009Unknown status
30
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
Condition(s):Non-Alcoholic Steatohepatitis; Non-Alcoholic Fatty Liver DiseaseLast Updated:December 10, 2019Recruiting
31
The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty Liver
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:August 29, 2019Recruiting
32
Response of Abdominal Fat to Focused Ultrasound in Fatty Liver Patients
Condition(s):Fatty LiverLast Updated:November 12, 2019Completed
33
Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese Population
Condition(s):Nonalcoholic Fatty Liver Disease; Atrial Fibrillation; Cross-sectional StudyLast Updated:June 20, 2019Completed
34
The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver
Condition(s):Fatty Liver, NonalcoholicLast Updated:August 8, 2019Completed
35
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:February 14, 2019Recruiting
36
Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver Disease; Non-alcoholic SteatohepatitisLast Updated:April 26, 2019Recruiting
37
Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis
Condition(s):Nonalcoholic Fatty Liver DiseaseLast Updated:December 19, 2017Terminated
38
Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:February 6, 2017Unknown status
39
Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease
Condition(s):Non-alcoholic Fatty Liver Disease; Sleep Apnea, ObstructiveLast Updated:January 15, 2019Recruiting
40
Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease
Condition(s):Patients With Fatty Liver DiseaseLast Updated:August 8, 2019Recruiting
41
Vitamin D Replacement in Nonalcoholic Fatty Liver Disease
Condition(s):Nonalcoholic Fatty LiverLast Updated:April 12, 2017Completed
42
Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:August 8, 2018Completed
43
Effect of Silymarin in Patients With Non-alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:March 2, 2019Recruiting
44
Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:July 26, 2017Completed
45
Fatty Liver Patient Registry
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:November 13, 2017Recruiting
46
The Effects of Zataria Multiflora Boiss (Shirazi’s Thyme) on Nonalcoholic Fatty Liver Disease
Condition(s):Fatty Liver; Fatty Liver, NonalcoholicLast Updated:October 3, 2017Completed
47
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:January 23, 2019Recruiting
48
Predictable MR Index for Nonalcoholic Steatohepatitis (NASH)
Condition(s):Nonalcoholic SteatohepatitisLast Updated:May 14, 2019Completed
49
Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease
Condition(s):Nonalcoholic Fatty Liver Disease; Nonalcoholic SteatohepatitisLast Updated:November 23, 2016Completed
50
Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis
Condition(s):Non-alcoholic SteatohepatitisLast Updated:March 7, 2019Recruiting
51
Interval Training Versus Electro Acupuncture on Liver Functions in Patients With Non-alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:November 10, 2019Completed
52
Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM
Condition(s):Fatty Liver; Diabetes Mellitus, Type 2Last Updated:April 5, 2019Enrolling by invitation
53
Impact of Graft Steatosis on Post-operative Complications After Liver Transplantation
Condition(s):Post-operative ComplicationsLast Updated:October 12, 2016Completed
54
Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)
Condition(s):Non-alcoholic Fatty Liver Disease; Nonalcoholic SteatohepatitisLast Updated:October 29, 2019Not yet recruiting
55
Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:February 20, 2019Recruiting
56
Omega 3 Supplementation in Fatty Liver
Condition(s):Fatty LiverLast Updated:November 19, 2013Completed
57
Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients
Condition(s):Fatty Liver; SteatohepatitisLast Updated:May 15, 2014Completed
58
Curcumin for Pediatric Nonalcoholic Fatty Liver Disease
Condition(s):NAFLD – Nonalcoholic Fatty Liver Disease; NASH – Nonalcoholic SteatohepatitisLast Updated:October 7, 2019Recruiting
59
Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or Obesity
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:March 20, 2019Recruiting
60
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease
Condition(s):Fatty LiverLast Updated:February 5, 2018Completed
61
Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant Neoplasm
Condition(s):Colorectal Neoplasms; Nonalcoholic Fatty Liver DiseaseLast Updated:August 3, 2012Completed
62
Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:January 6, 2016Completed
63
Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Condition(s):Fatty LiverLast Updated:November 22, 2019Completed
64
Hepaxa Management of Non-alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver Disease; Non Alcoholic Fatty Liver; NASH – Nonalcoholic SteatohepatitisLast Updated:January 10, 2019Not yet recruiting
65
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Condition(s):Nonalcoholic Fatty Liver Disease (NAFLD)Last Updated:August 2, 2017Completed
66
Fatty Acids, Genes and Microbiota in Fatty Liver
Condition(s):Nonalcoholic Fatty Liver Disease; Steatosis; Nonalcoholic SteatohepatitisLast Updated:May 10, 2016Completed
67
Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO)
Condition(s):Non-Alcoholic Fatty Liver Disease; Obese; OverweightLast Updated:June 7, 2017Unknown status
68
Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease
Condition(s):Non-alcoholic Fatty Liver Disease; Chronic Kidney Disease; Diabetes MellitusLast Updated:February 22, 2019Active, not recruiting
69
Metformin in Non-Alcoholic Fatty Liver Disease
Condition(s):Fatty LiverLast Updated:June 29, 2007Unknown status
70
An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis
Condition(s):Psoriasis Chronic; Liver Fibrosis; Fatty Liver; Non-alcoholic Fatty Liver DiseaseLast Updated:August 3, 2017Active, not recruiting
71
Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:June 9, 2010Unknown status
72
Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:October 9, 2018Completed
73
Therapeutic And Dietary Effects Of The Sublimated Mare’s Milk Supplement In Patients With Non-Alcoholic Steatohepatitis
Condition(s):Non-alcoholic SteatohepatitisLast Updated:September 7, 2018Recruiting
74
The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver Disease
Condition(s):Fatty LiverLast Updated:November 5, 2014Completed
75
The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Adults
Condition(s):Non-Alcoholic Fatty Liver Disease; Non Alcoholic SteatohepatitisLast Updated:May 10, 2017Unknown status
76
Fatty Liver Disease Collaborative Research in China
Condition(s):Fatty Liver; Fatty Liver, Alcoholic; Non-alcoholic Fatty Liver DiseaseLast Updated:August 3, 2015Recruiting
77
Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:October 3, 2017Completed
78
Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients
Condition(s):Chronic Hepatitis B; Hepatic SteatosisLast Updated:June 21, 2010Unknown status
79
Quantitative US for Hepatic Steatosis
Condition(s):Hepatic SteatosisLast Updated:November 25, 2019Recruiting
80
Evaluation the Safety and Efficacy of Montelukast in Treatment of Patients With Fatty Liver Disease
Condition(s):Fatty LiverLast Updated:September 10, 2019Recruiting
81
European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
Condition(s):Non-Alcoholic Fatty Liver Disease; Non-alcoholic Fatty Liver; Non-alcoholic SteatohepatitisLast Updated:December 5, 2019Recruiting
82
Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.
Condition(s):Non-alcoholic Fatty Liver Disease (NAFLD)Last Updated:September 20, 2019Not yet recruiting
83
Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy
Condition(s):Nonalcoholic Fatty Liver Disease; HIVLast Updated:July 29, 2019Completed
84
Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver Disease
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:June 21, 2018Completed
85
Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity
Condition(s):Fatty LiverLast Updated:April 24, 2015Completed
86
The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients
Condition(s):Non-alcoholic Fatty Liver Disease (NAFLD)Last Updated:March 28, 2017Withdrawn
87
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver
Condition(s):Fatty LiverLast Updated:February 22, 2018Completed
88
Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis
Condition(s):Non-alcoholic SteatohepatitisLast Updated:September 19, 2018Suspended
89
Alternate Day Fasting Combined and NAFLD for the Treatment of Non-alcoholic Fatty Liver Disease (NAFLD)
Condition(s):Non-Alcoholic Fatty Liver Disease; Obesity; Pre-diabetesLast Updated:September 24, 2019Enrolling by invitation
90
Curcumin Supplement in Nonalcoholic Fatty Liver Patients With Type 2 Diabetes
Condition(s):Type 2 Diabetes; Nonalcoholic Fatty LiverLast Updated:September 19, 2016Unknown status
91
Fatty Liver and Obstructive Sleep Apnea
Condition(s):Non-Alcoholic Fatty Liver Disease; Obstructive Sleep ApneaLast Updated:August 7, 2008Completed
92
Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver
Condition(s):Fatty LiverLast Updated:October 17, 2017Unknown status
93
Resveratrol in Patients With Non-alcoholic Fatty Liver Disease
Condition(s):Fatty LiverLast Updated:June 12, 2015Completed
94
Obesity and Nonalcoholic Fatty Liver Disease
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:June 13, 2018Completed
95
Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Disease
Condition(s):Non-alcoholic Steatohepatitis; Type 2 Diabetes MellitusLast Updated:April 4, 2019Withdrawn
96
Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease
Condition(s):Nonalcoholic Fatty Liver Disease; Light-to-moderate Alcohol Consumption; Type2 Diabetes MellitusLast Updated:July 2, 2019Completed
97
Nonalcoholic Fatty Liver Disease in Taiwanese Children
Condition(s):Fatty LiverLast Updated:April 7, 2019Completed
98
Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease
Condition(s):Fatty LiverLast Updated:July 11, 2018Completed
99
Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:October 3, 2016Completed
100
Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
Condition(s):Nonalcoholic Fatty Liver Disease; Type 2 Diabetes MellitusLast Updated:August 22, 2016Completed